Chronic Passive Heating in Healthy Older Adults
The Effects of Chronic Passive Heating on Vascular Function, Cognitive Function, Muscle Function and Heat Shock Protein Responses in Middle-aged to Older Adults: A Randomised, Controlled Crossover Trial
1 other identifier
interventional
19
1 country
1
Brief Summary
Aging is associated with a decline in cardiovascular health, cognitive function and losses in muscle strength, with half or more of those over age 65 suffering from two or more comorbidities (e.g., heart disease, type 2 diabetes). The worldwide population of older adults is growing rapidly, with one in six people expected to be over age 65 by 2050. This will place further financial burden from chronic diseases on already stressed healthcare systems. While studies show that frequent exercise is an effective way for older adults to maintain or improve cardiovascular and metabolic health, older individuals are less physically active and do not adhere well to exercise programs, often due to physical or medical limitations. Therefore, alternative methods for older adults to get the same health benefits as exercise require further exploration. Recent work has shown that passive heat therapy may be one such alternative solution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2022
CompletedFirst Posted
Study publicly available on registry
November 16, 2022
CompletedStudy Start
First participant enrolled
May 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2025
CompletedAugust 6, 2025
March 1, 2025
2 years
November 8, 2022
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brachial artery flow-mediated dilation
Percentage change from baseline in brachial artery diameter assessed by ultrasound.
Pre and post 6 weeks of passive heating and pre and post 6 weeks no intervention with 6 weeks washout between arms
Secondary Outcomes (33)
Brachial and carotid artery blood flow velocity
Pre and post 6 weeks of passive heating and pre and post 6 weeks no intervention with 6 weeks washout between arms
Carotid vessel diameter
Pre and post 6 weeks of passive heating and pre and post 6 weeks no intervention with 6 weeks washout between arms
Carotid intima-media thickness
Pre and post 6 weeks of passive heating and pre and post 6 weeks no intervention with 6 weeks washout between arms
Carotid compliance
Pre and post 6 weeks of passive heating and pre and post 6 weeks no intervention with 6 weeks washout between arms
Carotid distensibility
Pre and post 6 weeks of passive heating and pre and post 6 weeks no intervention with 6 weeks washout between arms
- +28 more secondary outcomes
Study Arms (2)
Passive heating intervention
EXPERIMENTAL\~3x per week of 1 h hot water immersion (to the clavicle, @40°C, rectal temperature \~38.5°C and \<39°C) sessions over a period of 6 weeks.
Control
NO INTERVENTION6 weeks of no hot water immersion
Interventions
\~3x per week of 1 h hot water immersion (to the clavicle, @40°C, rectal temperature \~38.5°C and \<39°C) sessions over a period of 6 weeks.
Eligibility Criteria
You may qualify if:
- Male or female age ≥ 55
- Free from cardiometabolic disease
- Body mass index of 18-35 kg/m2
- Receipt of a normal 12-lead ECG approved by the School Independent Medical Officer
- Capacity to understand and provide their written, informed consent to participate in the study protocol
You may not qualify if:
- Unable to understand or cooperate with the study protocol due to learning difficulties or otherwise
- Any current, or past medical (last five years), history of any cardiovascular, respiratory, cancer, renal, hepatic, gastrointestinal, haematological, lymphatic, neurological, psychiatric, or any other disease or diseases.
- Any regular medication for the last five years (not including acute courses of treatment of less than one month for discrete, resolved conditions).
- Medications that may influence physiological responses to the passive heating intervention Uncontrolled hypertension (≥ 150 mmHg systolic and/or ≥ 90 mmHg diastolic)
- Body mass index of \> 35 kg/m2
- Recent long-term exposure to a hot climate (within the previous three months)
- Current smoker (or have stopped smoking within the previous three months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Spinnaker Building
Portsmouth, Hampshire, PO4 0SU, United Kingdom
Study Officials
- STUDY DIRECTOR
Zoe Saynor, PhD
University of Portsmouth
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
November 8, 2022
First Posted
November 16, 2022
Study Start
May 23, 2023
Primary Completion
June 6, 2025
Study Completion
June 6, 2025
Last Updated
August 6, 2025
Record last verified: 2025-03